Skip to main content
. 2012 Oct 5;2(1):418–432. doi: 10.1159/000338228

Table 4.

Compliance to AD treatment and satisfaction reported by caregivers of patients receiving oral and transdermal formulation on a scale from 0 to 10 (CMI questions 2 and 3)

Oral Transdermal p
Compliance 9.09 ± 1.56 9.53 ± 1.20 <0.0001
Satisfaction 7.88 ± 2.16 8.42 ± 2.02 <0.0001